0001179110-12-012388.txt : 20120803 0001179110-12-012388.hdr.sgml : 20120803 20120803165326 ACCESSION NUMBER: 0001179110-12-012388 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120801 FILED AS OF DATE: 20120803 DATE AS OF CHANGE: 20120803 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Washington Robin L CENTRAL INDEX KEY: 0001327145 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 121007376 MAIL ADDRESS: STREET 1: PO BOX 500 (M/S 55-985) CITY: BEAVERTON STATE: OR ZIP: 97077-0001 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES INC CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 edgar.xml FORM 4 - X0306 4 2012-08-01 0 0000882095 GILEAD SCIENCES INC GILD 0001327145 Washington Robin L GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE FOSTER CITY CA 94404 0 1 0 0 SVP, CFO Common Stock 2012-08-01 4 A 0 6500 0 A 17913 D Common Stock 2012-08-01 4 F 0 3034 53.629 D 14879 D Common Stock 2012-08-02 4 M 0 17500 47.20 A 32379 D Common Stock 2012-08-02 4 S 0 17500 57.7297 D 14879 D Common Stock 2012-08-02 4 M 0 12000 47.51 A 26879 D Common Stock 2012-08-02 4 S 0 12000 57.7297 D 14879 D Non-Qualified Stock Option (right to buy) 47.20 2012-08-02 4 M 0 17500 0 D 2019-01-21 Common Stock 17500 32500 D Non-Qualified Stock Option (right to buy) 47.51 2012-08-02 4 M 0 12000 0 D 2020-01-28 Common Stock 12000 36000 D The exercise and sale transactions are pursuant to a Rule 105b-1 trading plan established by Ms. Washington on December 11, 2011. The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested. Issuance of common stock upon vesting of performance share awards on August 1, 2012. Sale prices reported for the transactions reported here range from $57.60 to $58.03. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request. /s/ Robin L. Washington 2012-08-03